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Various devices for transcatheter ASD closure are undergoing clinical 
trials. Each new device claims advantages in terms of safety and efficacy 
over earlier devices. We report three cases in which a new investigational 
device--the Das angel wingsmfailed. Emergency operations were necessary 
for device retrieval and defect closure. The possible mechanisms of the 
event and the options in management are discussed with a review of 
literature on all devices. (J Thorac Cardiovasc Surg 1996;112:21-6) 
T ranscatheter closure of atrial septal defects (ASDs) was introduced two decades ago. 1 Four 
devices have been described so far. The devices have 
been associated with occasional failures necessitat- 
ing their retrieval by transcatheter o  surgical means 
and occasional complications such as device embo- 
lization and transient ischemic attacks. 
In 1993 Das and colleagues 2 introduced a new 
device intended to decrease rates of failures and 
complications, and they used it successfully in a 
dog model. Recently an international clinical trial 
with this device was started. After a hospital ethics 
committee review was conducted for a monitored 
trial, six patients underwent implantation of the 
Das angel wings device at our center. The follow- 
ing criteria were used for patient selection: (1) a 
fossa ovalis ASD less than 20 mm as measured on 
echocardiography; (2) a left-to-right shunt of 1.5:1 
or more in the absence of severe pulmonary 
arterial hypertension; and (3) absence of other 
intracardiac defects necessitating surgical correc- 
tion. Informed consent was obtained from each 
patient. In three of these patients, the device was 
deployed successfully. Two patients made an un- 
eventful recovery and were discharged 48 hours 
after the procedure. In the third patient ransient 
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complete heart block developed but resolved after 
72 hours, and the patient was discharged after 1 
week. No residual shunt was detected at immedi- 
ate or follow-up echocardiography. All three pa- 
tients are doing well at 3 to 6 months' follow-up, 
and none has had infective endocarditis. 
We shall now describe three patients with acute 
failure of this device who required emergency sur- 
gical management. This is the first report of surgical 
management after failure of the angel wings device 
used for ASD closure. 
Case reports 
CASE 1. A 26-year-old woman with no symptoms was 
confirmed to have secundum ASD on echocardiography. 
Transvenous closure was attempted on February 26, 1995. 
A long 14F sheath shaped to enter the left atrium was 
placed in the right femoral vein and a 5F sheath was 
placed in the femoral artery for pressure measurements. 
Under fluoroscopic control, a balloon was used to mea- 
sure the stretched iameter of the ASD. A 30 mm Das 
device was implanted to occlude the ASD. After the 
device was released, it slipped back into the right atrium. 
It was snared and retrieved up to the right common iliac 
vein but could be advanced no further. The device was left 
in this position. A second attempt was made from the left 
femoral vein with a 35 mm device. This too slipped into 
the right atrium. At an emergency operation, the d vice 
was easily identified and removed after the right atrium 
was opened. The ASD was closed by direct sutures. The 
patient was weaned uneventfully from cardiopulmonary 
bypass. Through a vertical incision in the right groin, the 
other device was removed from the right common iliac 
vein. The vein was then directly repaired. The patient 
recovered without complications and was discharged on 
the sixth postoperative day. 
CASE 2. A 23-year-old woman with secundum ASD 
underwent transcatheter closure on April 25, 1995. A 40 
mm Das device was inserted via the right femoral vein. 
The device was successfully implanted, but within seconds 
of implantation it slipped into the left atrium. It could not 
be retrieved by being snared. The woman was in hemo- 
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Table I. Clinical details of cases 
Case 1 Case 2 Case 3 
Weight (kg) 
RA size (mm) 
LA size (ram) 
Stretched ASD 
diameter (mm) 
PAP s/d/m 
Qp/Qs 
PVRI 
Device size (mm) 
Femoral sheath 
Complication 
Operation 
43 40 50 
50 40 49 
40 31 40 
5 to 18 16 to 18 16 to 22 
44/16/24 
8.4:1 
0.72 
30, 35 
14F 
First device slipped into RA and 
was extracted from RCIV; 
second slipped into RA 
1.5 × 1.0 cm FO ASD; 
second device in RA; 
first device in RCIV 
removed by venotomy 
15/0/6 32/6/16 
2.07:1 3.48:1 
1.03 1.11 
40 35 
14F 14F 
Slipped into LA Slipped into LA 
1.2 × 0.7 cm ASD; device in LA; 
one flange across MV orifice 
2.6 × 1.2 cm ASD; device in LA 
RA, Right atrium; LA, left atrium; ASD, atrial septal defect; PAP, pulmonary arterial pressure; , systolic; d, diastolic; m, mean; Qp, pulmonary blood flow; 
Qs, systemic blood flow; PVR, pulmonary vasculature resistance (indexed); RCIV, right common iliac vein; FO, fossa ovalis; MV, mitral valve. 
dynamically stable condition when taken for an emer- 
gency operation to retrieve the device and close the 
defect. The device was seen in the left atrium through a 2 
cm ASD with a nonfibrous inferior margin. The device 
was retrieved through the ASD and the defect was closed 
directly. The patient made an uneventful recovery and was 
discharged. She r mains well at 2 months' follow-up. 
CASE 3. A 30-year-old woman with asymptomatic secun- 
dum ASD elected to undergo device closure of the ASD 
on April 26, 1995. A 35 mm Das device was used for 
implantation, but it could not be properly released. On a 
second attempt, after release of the second disc, it slipped 
into the left atrium. The patient's condition remained 
hemodynamically stable. At emergency operation the 
ASD, seen through a right atriotomy, was 1.6 cm in 
diameter with good margins. The device was easily iden- 
tified lying in the left atrium and was removed through the 
defect. The ASD was closed primarily. The woman recov- 
ered without complications and was discharged on the 
seventh postoperative day. She is free of symptoms and 
doing well at 2 months' follow-up. The details of the 
echocardiographic, catheterization, and surgical findings 
of all three patients are given in Table I. 
The failure in these three cases may be ascribed to 
technical reasons and lack of operator expertise. In one 
case the fact that the device was too large led to difficulty 
in manipulation and proper positioning of the left atrial 
disc. In the other two the device slipped back after 
deployment. The operations were necessary because the 
design of the device made transcatheter retrieval difficult. 
Although the use of an ASD closure device was new for 
this institution, the principal investigators (who performed 
the procedures) are widely experienced in invasive proce- 
dures and have a high success rate with transcatheter 
ductus closure in this institution. 
Discussion 
ASD is the fifth most common congenital cardiac 
anomaly and occurs with a frequency of 3.2/10,000 
live births. 3 It is being detected with even greater 
frequency because of the more widespread use of 
echocardiography. Surgical management of ASDs is 
safe and simple but is associated with occasional 
mortality, morbidity, and high expenses. Patent fo- 
ramen ovale, with a prevalence at autopsy of 27% to 
35%, 4 may cause paradoxic embolism 5 and necessi- 
tate surgical closure to prevent this complication. 
Interatrial communication after a fenestrated Fon- 
tan procedure may also indicate closure of  the 
defect at a later date. With a view to decreasing the 
cost, hospital stay, and surgical complications, trans- 
venous closure of these defects was introduced. 
After the first report of such a device by King and 
associates 1 in 1976, several such devices were devel- 
oped. Two devices (Lock clamshell 6 and Sideris 
buttoned device 7) have undergone clinical trials. 
Table I I  describes various devices and their main 
features. Table I I l  is a brief review of the literature 
concerning use of these devices in various sub- 
groups. All devices have been associated with in- 
stances of failure and complications (Table III). The 
clamshell device has been withdrawn and is under- 
going further modifications. 
There are several reasons for acute failure of 
these devices. The most important mechanism is 
poor case selection (i.e., too large a defect) or device 
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Table II. Types of ASD closure devices 
Device name Reference Features 
Minimum size 
of Femoral 
sheath required Current 
for deployment status 
King umbrella King et al. 1 (1974) 
Rashkind umbrella 
Bard clamshell 
Rashkind s (1983) 
Lock et al. 6 (1989) 
Sideris buttoned Sideris et al. v 
occluder (1990) 
Das angel wing Das et al. 2 (1993) 
Two Dacron discs with 
stainless steel skeletons 
resembling umbrellas; complex 
delivery mechanism; bulky 
Single disc occluder of 
polyurethane foam; three of 
six wires comprising its 
umbrella-like skeletons end 
in small sharp hooks that 
imbed into atrial septum; 
cannot be retrieved 
Double disc composed of woven 
Dacron fabric over a complex 
multiple-jointed wire skeleton 
with a metal knuckle extending 
from the center to attach 
the device to the delivery system 
Two discs of polyurethane foam 
over a metal skeleton of Teflon-coated 
stainless steel wire-guide material, 
inserted separately and 
sequentially, positioned on each 
side of the atrial septum and then 
"buttoned" together; the button is 
made by a short loop of nylon 
suture attached to the 
skeleton center that contains a
knot with a radiopaque marker 
Double disc of polyester with 
nitinol skeleton, which forms a 
square at the periphery of 
each disc; no central wire skeleton; 
two discs are sewn together in a 
central oval area; knuckle 
and eye release system on 
one corner of right-sided isc 
23F Currently not used 
16F Currently not used 
11F Clinical trials underway 
11F Clinical trials underway 
13F Investigational (study 
patients are 
part of first 
clinical trial) 
selection (low ratio of device to defect). Rao and 
associates ~9have described protocols for the selec- 
tion of patients and devices. Rosenfeld and cowork- 
ers 17 described echocardiographic predictors of can- 
didacy for successful transcatheter closure of these 
defects. They found that the success rate was only 
59% in ASDs larger than 13 mm as compared with 
100% in defects smaller than 13 ram. The other 
suggested mechanisms of acute failure are (1)oper- 
ator-related failure resulting from inadequate expe- 
rience (learning curve), (2) inaccurate deployment, 
(3) inadequate defect rim to hold the device, (4) 
tearing of the interatrial septum especially at the 
lower rim of the ASD owing to catheter and device 
manipulations, 2° and (5) the failure to button the 
Sideris buttoned occluder or unbuttoning of this 
occluder. 19 Chronic/late failure has been reported to 
result from unbuttoning and fracture of the wire 
framework of the Sideris device. 21 Various compli- 
cations may occur. A part of the device or the whole 
device may embolize to the right or left atrium, main 
pulmonary artery, or even to other parts of the 
vascular tree on both the right and left sides of the 
circulation)0-12, 19 22 Thromboembolic episodes 
may occur as a result of poor endothelialization f 
these devices, necessitating long-term use of antico- 
agulants or even surgical removal of the device. ~4 
Other reports have described atrial perforation and 
hemopericardium. 19 Atrial arrhythmia and atrioven- 
tricular valve regurgitation may be caused by the 
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Table IlL Review of ASD closure device failures andcomplications 
First Total No. No. Cause of 
Year author patients successful failures failures 
I. King double disc umbrella 
1. 1976 King ~ 5 5 - -  - -  
II. Rashkind umbrella 
2. 1983 Rashkind s 20 13 7 Residual shunt in 3 
Improper deployment in 4 
3. 1989 Beekman 9 5 2 3 
4. 1994 Redington 1° 16 12 2 IVC thrombosis in 1 
IVC spasm in 1 
III. Lock clamshell 
5. 1990 
6. 1991 
Rome n* 40 32 6 NR 
Latson12t 400 376 7 NR 
7. 1992 Bridges 13 36 (PFO) 36 Nil 
8. 1992 Prewitt TM 1 1 - -  
9. 1992 RuizlS:~ 1 1 - -  
10. 1993 O'Laughlin 16 1 1 - -  
11. 1995 Rosenfeld 17 132 129 3 
IV. Sideris button 
12. 1991 Walsh 18 8 7 1 
13. 1994 Rao 19 190 166 10 
m 
m 
Unstable position 
Inadvertently 
pulled through 
Delivered into LA but 
occluder pulled 
through in 7 
Unstable device in 3 
14. 1995 Gutti 2° 3 2 1 
V. Das angel wing 
15. 1995 Present report 6 3 3 
(7 devices) (4 devices) 
Unstable device 
Device slipped in LA (2) 
Device slipped in RA 
(1 patient, 2 devices) 
PFO, Patent foramen ovale; IVC, Inferior vena cava; NR, not reported; LA, left atrium; RA, right atrium; MPA, main pulmonary artery; T/A, transient 
ischemic attack; ASD, atrial septal defect; MR, mitral regurgitation; TR, tricuspid regurgitation; RCIV, right common iliac vein. 
*Includes 12 Rashkind and 3 modified Rashkind evices. 
?Included some cases reported in references 5, 7, 11, and 12. 
SAs rescue procedure with MVBD and AVBD. 
device impinging on the atrial tissue or atrioventric- 
ular valves. Also, a high rate of residual shunt has 
been reported with the use of these devices. In the 
cumulative global experience (with all types of de- 
vices) in nearly 900 patients, the device failure rate 
is about 5% and the complication rate is 9%. 
Surgical intervention has already been performed in 
4% for complications and failure, and another 4% 
will undergo perations for device failure. 
Das and associates 2 developed their new device 
with the intention of reducing these failures and 
complications. The nitinol wire framework at the 
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Management of Management of Residual 
failures Complications complications shunt 
- -  - -  - -  3 (1 trivial, 2 clinical) 
Surgery in 5 (emergency in 4) - -  - -  3 
NR Unstable device in 1 Surgery in 2 1 (trivial) 
Embolization to MPA in 1 
NR Cath-related cerebral death in 1 Surgery in 2 1 (trivial) 
Embolization to common iliacs 2 
Removed before release Embolization in 17 (3 systemic) NR 33% 
Vessel damage in 2 
Air embolism in 6 
- -  Brachial plexus injury in 1 NR 5/34 studied 
TIAin 4 
- -  30% wire fracture at hinge; TIA after 6 mo Surgery (device removal) - -  
- -  - -  - -  Small residual shunt 
Removed (2 catheter, 1 surgery) - -  - -  4 (significant) 
- -  - -  - -  2 (trivial) 
Retrieved in 10 Unbuttoning and embolism in 13 Embolism, catheter 76 (62 trivial, 11 small, 
removal in 4 3 moderate) 
Transcatheter in 7 Whole device in 1 Surgery in 10 
Femoral vein cutdown in 2 
Surgery in 1 
Transcatheter removal 
Surgery in 3 
One device removed through 
RCIV by cath, then venotomy 
Atrial perforations in 2 
Residual shunt in 2 
Transient atrial arrhythmias in 1 
Trivial MR in 3 
Trivial TR in 2 
Few cases of right-sided air bubble 
Wire distortion at 6 month in 2 
Embolization to axillary artery in 1 
Paradoxic embolism (TIA) in 1 
Tear of inferior rim of ASD 
found at surgery 
Transient heart block in 1 
Surgery in 3 
Removal of wire, device left 
behind in 2
Surgery in 1 
Surgery NR 
Nil 
periphery of the Dacron fabric disc serves to keep 
the edges of the discs in close apposition to he atrial 
septum, and the large central connection between 
the two discs is supposed to reduce the tendency of 
the device to move along the atrial septum, poten- 
tially reducing the device/defect ratio. A special 
delivery system was designed to permit precise and 
reliable deployment of the device. The device has 
been successfully used in animal models, and clinical 
investigations were started in 1995. 
The management of failures and complications 
usually involves snaring and transcatheter etrieval 
of the device with later surgical closure of the defect. 
However, if the device cannot be retrieved or causes 
complications (e.g., device embolization or atrial 
perforation) posing an emergency, prompt surgical 
management is required. In some instances in which 
the device is not obstructing any cardiac valve or 
vessel lumen, with a small and self-limiting atrial 
leak, and a stable hemodynamic state, the patients 
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may be regularly followed up until elective surgical 
closure of the defects. 
Although devices are useful alternatives to surgi- 
cal closure in selected cases, they are not without 
attendant failures and complications. The state-of- 
the-art devices have not yet proven to be superior to 
presently available devices. Thus a proper selection 
of patient and device is required. Close monitoring 
and facilities for emergency surgical management 
should be available for all patients while an experi- 
enced operator deploys the device across the inter- 
atrial communication. Use of the devices is currently 
indicated in patients who have small defects with a 
patent foramen ovale and paradoxic embolism, in- 
teratrial communications after a fenestrated Fontan 
operation, and in children and adults who cannot 
undergo a surgical procedure. Use of these devices 
may buy time in some and may avoid surgery 
altogether in others. 
Contributions to patient care by the staff of the Depart- 
ments of Cardiovascular and Thoracic Surgery, Cardiol- 
ogy, and Anesthesiology and by Professor Das are ac- 
knowledged. 
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